5-HTTLPR genotype and daily negative mood moderate the effects of sertraline on drinking intensity

Addiction Biology

Volumn 18, Issue 6, 2013, Pages 1024-1031

  Kranzler, Henry R ^a,b   Armeli, Stephen ^c   Tennen, Howard ^d   Covault, Jonathan ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c FAIRLEIGH DICKINSON UNIVERSITY   (United States)

^d UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

5 HTTLPR; alcohol dependence; SSRI

Indexed keywords

PLACEBO; SEROTONIN TRANSPORTER; SERTRALINE;

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOLISM; ALLELE; ANGER; ANXIETY; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRINKING BEHAVIOR; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; ONSET AGE; PHARMACOGENETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM;

5-HTTLPR; ALCOHOL DEPENDENCE; SSRI;

ADOLESCENT; ADULT; AFFECT; AGE OF ONSET; AGED; ALCOHOL DRINKING; ALCOHOLIC BEVERAGES; ALCOHOLISM; ALLELES; ANTIDEPRESSIVE AGENTS; ANXIETY; DOUBLE-BLIND METHOD; FEMALE; GENOTYPE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PLACEBOS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SERTRALINE; TIME FACTORS; YOUNG ADULT;

EID: 84889244777     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/adb.12007     Document Type: Article

References (35)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association.
2. Armeli S, Tennen H, Affleck G, Kranzler HR, (2000) Does affect mediate the association between daily events and alcohol use? J Stud Alcohol 61: 862-871.
3. Babor TF, Hofmann M, DelBoca FK, Hesselbrock V, Meyer RE, Dolinsky ZS, Rounsaville B, (1992) Types of alcoholics, I. Evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch Gen Psychiatry 49: 599-608.
4. Browning M, Reid C, Cowen PJ, Goodwin GM, Harmer CJ, (2007) A single dose of citalopram increases fear recognition in healthy subjects. J Psychopharmacol 21: 684-690. (Pubitemid 47437913)
5. Buydens-Branchey L, Branchey MH, Noumair D, (1989) Age of alcoholism onset. I. Relationship to psychopathology. Arch Gen Psychiatry 46: 225-230. (Pubitemid 19078258)
6. Chick J, Aschauer H, Hornik K, (2004) Efficacy of fluvoxamine in preventing relapse in alcohol dependence: a one-year, double-blind, placebo-controlled multicentre study with analysis by typology. Drug Alcohol Depend 74: 61-70. (Pubitemid 38457054)
7. Covault J, Tennen H, Armeli S, Conner TS, Herman AI, Cillessen AH, Kranzler HR, (2007) Interactive effects of the serotonin transporter 5-HTTLPR polymorphism and stressful life events on college student drinking and drug use. Biol Psychiatry 61: 609-616. (Pubitemid 46328860)
8. Coxe S, West SG, Aiken LS, (2009) The analysis of count data: a gentle introduction to poisson regression and its alternatives. J Pers Assess 91: 121-136.
9. Davey HM, Barratt AL, Butow PN, Deeks JJ, (2007) A one-item question with a Likert or visual analog scale adequately measured current anxiety. J Clin Epidemiol 60: 356-360. (Pubitemid 46341708)
10. First M, Spitzer R, Gibbon M, (2001) Structured Clinical Interview for DSM-IC-TR Axis I Disorders, Research Version, Patient Edition with Psychotic Screen (SCID-I/P W/PSYSCREEN). New York: Biometric Research and New York State Psychiatric Institute.
11. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL, (1999) Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 88: 83-87. (Pubitemid 29075327)
12. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP, (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66: 2621-2624. (Pubitemid 26159101)
13. Hu X, Oroszi G, Chun J, Smith TL, Goldman D, Schuckit MA, (2005) An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res 29: 8-16. (Pubitemid 40129206)
14. Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, Xu K, Arnold PD, Richter MA, Kennedy JL, Murphy DL, Goldman D, (2006) Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 78: 815-826.
15. Johnson BA, Ait-Daoud N, Seneviratne C, Roache JD, Javors MA, Wang XQ, Liu L, Penberthy JK, DeClemente CC, Li MD, (2011) Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking. Am J Psychiatry 168: 265-275.
16. Johnson BA, Cloninger CR, Roache JD, Bordnick PS, Ruiz P, (2000) Age of onset as a discriminator between alcoholic subtypes in a treatment-seeking outpatient population. Am J Addict 9: 17-27. (Pubitemid 30155030)
17. Kranzler HR, Abu-Hasaballah K, Tennen H, Feinn R, Young K, (2004) Using daily interactive voice response technology to measure drinking and related behaviors in a pharmacotherapy study. Alcohol Clin Exp Res 28: 1060-1064. (Pubitemid 38955204)
18. Kranzler HR, Armeli S, Covault J, Tennen H, (2012) Variation in OPRM1 moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment. Addict Biol. doi: 10.1111/j.1369-1600.2012. 00471.x [Epub ahead of print].
19. Kranzler HR, Armeli S, Tennen H, Covault J, Feinn R, Arias AJ, Pettinati H, Oncken C, (2011) A double-blind, randomized trial of sertraline for alcohol dependence: moderation by age of onset [corrected] and 5-hydroxytryptamine transporter-linked promoter region genotype. J Clin Psychopharmacol 31: 22-30.
20. Kranzler HR, Burleson JA, Brown J, Babor TF, (1996) Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics. Alcohol Clin Exp Res 20: 1534-1541. (Pubitemid 26428102)
21. Kurt M, Arik AC, Celik S, (2000) The effects of sertraline and fluoxetine on anxiety in the elevated plus-maze test in mice. J Basic Clin Physiol Pharmacol 11: 173-180.
22. Larsen R, Diener E, (1992) Promises and problems with the circumplex model of emotion. In:, Clark M, ed. Review of Personality and Social Psychology, pp. 25-59. Newbury Park, CA: Sage.
23. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL, (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274: 1527-1531. (Pubitemid 26403928)
24. Mittleman MA, Maclure M, Nachnani M, Sherwood JB, Muller JE, (1997) Educational attainment, anger, and the risk of triggering myocardial infarction onset. The Determinants of Myocardial Infarction Onset Study Investigators. Arch Intern Med 157: 769-775. (Pubitemid 27164451)
25. Murphy DL, Lerner A, Rudnick G, Lesch KP, (2004) Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Mol Interv 4: 109-123. (Pubitemid 38584973)
26. Nakamura M, Ueno S, Sano A, Tanabe H, (2000) The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry 5: 32-38. (Pubitemid 30088450)
27. Olfson M, Marcus SC, (2009) National patterns in antidepressant medication treatment. Arch Gen Psychiatry 66: 848-856.
28. Perroud N, Salzmann A, Saiz PA, Baca-Garcia E, Sarchiapone M, Garcia-Portilla MP, Carli V, Vaquero-Lorenzo D, Jaussent I, Mouthon D, Vessaz M, Huguelet P, Courtet P, Malafosse A, (2010) Rare genotype combination of the serotonin transporter gene associated with treatment response in severe personality disorder. Am J Med Genet B Neuropsychiatr Genet 153B: 1494-1497.
29. Pettinati HM, Volpicelli JR, Kranzler HR, Luck G, Rukstalis MR, Cnaan A, (2000) Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype. Alcohol Clin Exp Res 24: 1041-1049. (Pubitemid 30604324)
30. Praschak-Rieder N, Kennedy J, Wilson AA, Hussey D, Boovariwala A, Willeit M, Ginovart N, Tharmalingam S, Maselis M, Houle S, Meyer JH, (2007) Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study. Biol Psychiatry 62: 327-331. (Pubitemid 47444277)
31. Skoogh J, Ylitalo N, Larsson Omerov P, Hauksdottir A, Nyberg U, Wilderang U, Johansson B, Gatz M, Steineck G, (2010) 'A no means no'-measuring depression using a single-item question versus Hospital Anxiety and Depression Scale (HADS-D). Ann Oncol 21: 1905-1909.
32. Stone A, Shiffman S, (1994) Ecological momentary assessment (EMA) in behavioral medicine. Anns Behav Med 16: 199-202. (Pubitemid 24280823)
33. Todd M, Armeli S, Tennen H, Carney MA, Affleck G, (2003) A daily diary validity test of drinking to cope measures. Psychol Addict Behav 17: 303-311. (Pubitemid 37509918)
34. van Hooff ML, Geurts SA, Kompier MA, Taris TW, (2007) 'How fatigued do you currently feel?' Convergent and discriminant validity of a single-item fatigue measure. J Occup Health 49: 224-234. (Pubitemid 47036471)
35. Wei L, (1978) An application of a URN model to the design of sequential controlled clinical trials. J Amer Statistic Assoc 73: 559-563.